Azitra, Inc. (NYSEAMERICAN:AZTR) Shares Shorted: Short Interest Down 53.4% in October

Azitra, Inc. (NYSEAMERICAN:AZTR) saw a large drop in short interest during the month of October. As of October 15th, there was short interest totaling 112,293 shares, a drop of 53.4% from the September 30th total of 240,809 shares. Based on an average daily volume of 667,182 shares, the short-interest ratio is currently 0.2 days. Currently, 0.2% of the shares of the company are short sold.

Azitra Trading Up 1.6%

NYSEAMERICAN AZTR traded up $0.01 during trading on Friday, reaching $0.77. The company’s stock had a trading volume of 782,984 shares, compared to its average volume of 8,033,131. Azitra has a twelve month low of $0.52 and a twelve month high of $5.59. The business’s fifty day moving average price is $1.90 and its 200-day moving average price is $1.96.

Azitra (NYSEAMERICAN:AZTR) last announced its earnings results on Wednesday, August 12th. The company reported ($1.70) EPS for the quarter, missing analysts’ consensus estimates of ($1.15) by ($0.55). Analysts expect that Azitra will post -2.00 earnings per share for the current year.

Azitra Company Profile

Azitra, Inc is a clinical-stage biotechnology company focused on developing microbiome-based therapies for dermatological conditions. The company combines microbiology, genetic engineering and computational tools to identify and develop targeted treatments intended to address diseases affecting the skin.

Azitra’s platform centers on engineered strains of beneficial skin bacteria and biologic compounds designed to deliver therapeutic proteins or otherwise influence the skin’s local environment.